The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
Open accessAbstract
Background: Migraine prevention guidelines recommend oral prophylactic medications for patients with frequent headache. This study examined oral migraine preventive medication (OMPM) treatment patterns by evaluating medication persistence, switching, and re-initiation in patients with chronic migraine (CM). Methods: A retrospective US claims analysis (Truven Health MarketScan® Databases) evaluated patients ≥18 years old diagnosed with CM who had initiated an OMPM between 1 January, 2008 and 30 September, 2012. Treatment persistence was measured at six and 12 months’ follow-up. Time-to-discontinuation was assessed for each OMPM and compared using Cox regression models. Among those who discontinued, the proportion that switched OMPMs within 60 days or re-initiated treatment between 61 to 365 days, and their associated persistence rates, were also assessed. Results: A total of 8707 patients met the inclusion/exclusion criteria. Persistence to the initial OMPM was 25% at six months and 14% at 12 months. Based on Kaplan-Meier curves, a sharp decline of patients discontinuing was observed by 30 days, and approximately half discontinued by 60 days. Similar trends in time-to-discontinuation were seen following the second or third OMPM. Amitriptyline, gabapentin, and nortriptyline had significantly higher likelihood of non-persistence compared with topiramate. Among patients who discontinued, 23% switched to another prophylactic and 41% re-initiated therapy within one year. Among patients who switched, persistence was between 10 to 13% and among re-initiated patients, persistence was between 4 to 8% at 12 months. Conclusions: Persistence to OMPMs is poor at six months and declines further by 12 months. Switching between OMPMs is common, but results indicate that persistence worsens as patients cycle through various OMPMs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The International Classification of Headache Disorders, 3rd edition (beta version)
Headache Classification Committee of the International Headache Society (IHS) (2013) · Cephalalgia · doi:10.1177/0333102413485658 · Cited by 8,229
Migraine prevalence, disease burden, and the need for preventive therapy
Lipton, R. B., Bigal, M. E., Diamond, M., Freitag, F., Reed, M. L., & Stewart, W. F. (2007) · Neurology · doi:10.1212/01.wnl.0000252808.97649.21 · Cited by 2,337
Silberstein, S. D., Holland, S., Freitag, F., Dodick, D. W., Argoff, C., & Ashman, E. (2012) · Neurology · doi:10.1212/wnl.0b013e3182535d20 · Cited by 897
Self-citationGlobal prevalence of chronic migraine: A systematic review
Natoli, J., Manack, A., Dean, B., Butler, Q., Turkel, C., Stovner, L., & Lipton, R. (2010) · Cephalalgia · doi:10.1111/j.1468-2982.2009.01941.x · Cited by 693
Blumenfeld, A., Varon, S., Wilcox, T., Buse, D., Kawata, A., Manack, A., Goadsby, P., & Lipton, R. (2011) · Cephalalgia · doi:10.1177/0333102410381145 · Cited by 627 · cited 3×
“37(5) 470–485 ! International Headache Society 2016 Reprints and permissions: sagepub.”
BackgroundResultSelf-citationDiener, H.-C., Bussone, G., Oene, J. V., Lahaye, M., Schwalen, S., & Goadsby, P. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01326.x · Cited by 561
Buse, D. C., Manack, A. N., Fanning, K. M., Serrano, D., Reed, M. L., Turkel, C. C., & Lipton, R. B. (2012) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2012.02223.x · Cited by 549
Comparing Adherence and Persistence Across 6 Chronic Medication Classes
Yeaw, J., Benner, J. S., Walt, J. G., Sian, S., & Smith, D. B. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.9.728 · Cited by 549
Silberstein, S. D., Lipton, R. B., Dodick, D. W., Freitag, F. G., Ramadan, N., Mathew, N., Brandes, J. L., Bigal, M., Saper, J., Ascher, S., et al. (2007) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00684.x · Cited by 497
Self-citationAdherence to oral migraine-preventive medications among patients with chronic migraine
Hepp, Z., Dodick, D. W., Varon, S. F., Gillard, P., Hansen, R. N., & Devine, E. B. (2015) · Cephalalgia · doi:10.1177/0333102414547138 · Cited by 433
Self-citationMigraine: Epidemiology, Impact, and Risk Factors for Progression
Lipton, R. B., & Bigal, M. E. (2005) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2005.4501001.x · Cited by 417
Blumenfeld, A. M., Bloudek, L. M., Becker, W. J., Buse, D. C., Varon, S. F., Maglinte, G. A., Wilcox, T. K., Kawata, A. K., & Lipton, R. B. (2013) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12055 · Cited by 380
Self-citationSystematic Review of Migraine Prophylaxis Adherence and Persistence
Hepp, Z., Bloudek, L. M., & Varon, S. F. (2014) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2014.20.1.22 · Cited by 333
Self-citationLantéri-Minet, M., Duru, G., Mudge, M., & Cottrell, S. (2011) · Cephalalgia · doi:10.1177/0333102411398400 · Cited by 303 · cited 1×
“Patients with CM also use significantly more resources, including increased healthcare provider visits, emergency department visits, and diagnostic testing (3,5,6).”
BackgroundHazard, E., Munakata, J., Bigal, M. E., Rupnow, M. F. T., & Lipton, R. B. (2009) · Value in Health · doi:10.1111/j.1524-4733.2008.00404.x · Cited by 167
Adherence with Migraine Prophylaxis in Clinical Practice
Berger, A., Bloudek, L. M., Varon, S. F., & Oster, G. (2012) · Pain Practice · doi:10.1111/j.1533-2500.2012.00530.x · Cited by 118
Self-citationNoncompliance May Render Migraine Prophylaxis Useless, But Once-Daily Regimens Are Better
Mulleners, W., Whitmarsh, T., & Steiner, T. (1998) · Cephalalgia · doi:10.1046/j.1468-2982.1998.1801052.x · Cited by 94
Yaldo, A. Z., Wertz, D. A., Rupnow, M. F. T., & Quimbo, R. M. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.12.010 · Cited by 39
The Use of Migraine Preventive Medications Among Patients with and without Migraine Headaches
Lafata, J. E., Tunceli, O., Cerghet, M., Sharma, K., & Lipton, R. B. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2009.01909.x · Cited by 39
Cited by
A Phase‐by‐Phase Review of Migraine Pathophysiology
Dodick, D. W. (2018) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13300 · Cited by 505
Self-citationReuter, U., Goadsby, P. J., Lanteri-Minet, M., Wen, S., Hours-Zesiger, P., Ferrari, M. D., & Klatt, J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32534-0 · Cited by 457
Sacco, S., Amin, F. M., Ashina, M., Bendtsen, L., Deligianni, C. I., Gil-Gouveia, R., Katsarava, Z., MaassenVanDenBrink, A., Martelletti, P., Mitsikostas, D.-D., et al. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-022-01431-x · Cited by 410
Tassorelli, C., Diener, H.-C., Dodick, D. W., Silberstein, S. D., Lipton, R. B., Ashina, M., Becker, W. J., Ferrari, M. D., Goadsby, P. J., Pozo-Rosich, P., et al. (2018) · Cephalalgia · doi:10.1177/0333102418758283 · Cited by 388
“Comments: Adherence to preventive treatment for migraine is often poor (27,28), resulting in decreased efficacy.”
BackgroundSelf-citationEfficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2
Lipton, R. B., Goadsby, P. J., Smith, J., Schaeffler, B. A., Biondi, D. M., Hirman, J., Pederson, S., Allan, B., & Cady, R. (2020) · Neurology · doi:10.1212/wnl.0000000000009169 · Cited by 388
Metadata
- Authors
- Hepp, Z., Dodick, D. W., Varon, S. F., Chia, J., Matthew, N., Gillard, P., Hansen, R. N., & Devine, E. B.
- Venue
- Cephalalgia
- Publisher
- SAGE Publications
- Published
- 2016-11-12
- Volume
- 37
- Issue
- 5
- Pages
- 470-485
- ISSN
- 0333-1024 (ISSN-L)
- 1468-2982
- OpenAlex
- W2549116677
- Cited by
- 359
- References
- 19
- FWCI
- 17.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.